297 Manufacture of KSQ-001, a CRISPR/Cas9-engineered TIL (eTIL) therapy, for the treatment of head and neck squamous cell carcinoma von Wong, Karrie, Williams, Leila, Constant, Nick, Ghose, Mitali, Lin, Sharon, Thompson, Frank, Calnan, Conor, Sharp, Fiona, Donnelly, Sean, Quinn, Charles, Hanna, Glenn, Stegmeier, Frank, Benson, Micah

Volltext